Prevention of lung injury by Muc1 mucin in a mouse model of repetitive Pseudomonas aeruginosa infection

Inflammation Research

Volumn 61, Issue 9, 2012, Pages 1013-1020

  Umehara, Tsuyoshi ^a,c   Kato, Kosuke ^a   Park, Yong Sung ^a   Lillehoj, Erik P ^b   Kawauchi, Hideyuki ^c   Kim, Kwang Chul ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c SHIMANE UNIVERSITY   (Japan)

Author keywords

Airspace enlargement; Inflammation; MUC1 mucin; Pseudomonas aeruginosa; Respiratory

Indexed keywords

MUCIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CHRONIC LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; INFLAMMATORY CELL; KNOCKOUT MOUSE; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; LUNG LAVAGE; MOUSE; NONHUMAN; PNEUMONIA; PROTEIN DEPLETION; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REINFECTION; RESPIRATORY TRACT INFECTION; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; DISEASE MODELS, ANIMAL; INTERLEUKIN-8; LUNG INJURY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUCIN-1; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865121303     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-012-0494-y     Document Type: Article

References (56)

1. Levison ME, Kaye D. Pneumonia caused by gram-negative bacilli: an overview. Rev Infect Dis 1985;7 Suppl 4:S656-65.
2. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med. 2003;168(8):918-51. (Pubitemid 37267172)
3. Afessa B, Green B. Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study. Chest. 2000;117(4):1017-22. (Pubitemid 30228357)
4. Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest. 1998;113(6): 1542-8. (Pubitemid 28307157)
5. Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J. 1999;14(5):1015-22.
6. Miravitlles M, Espinosa C, Fernandez-Laso E, Martos JA, Maldonado JA, Gallego M. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest. 1999;116(1):40-6. (Pubitemid 29340258)
7. Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002;347(7):465-71. (Pubitemid 34879333)
8. Groenewegen KH, Wouters EF. Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study. Respir Med. 2003;97(7):770-7. (Pubitemid 36763889)
9. Eidelman D, Saetta MP, Ghezzo H, Wang NS, Hoidal JR, King M, et al. Cellularity of the alveolar walls in smokers and its relation to alveolar destruction: functional implications. Am Rev Respir Dis. 1990;141(6):1547-52. (Pubitemid 20201359)
10. Finkelstein R, Fraser RS, Ghezzo H, Cosio MG. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med. 1995;152(5 Pt 1):1666-72. (Pubitemid 3002087)
11. Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med. 1998;158(4):1277-85. (Pubitemid 28489033)
12. Betsuyaku T, Nishimura M, Takeyabu K, Tanino M, Venge P, Xu S, et al. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med. 1999;159(6):1985-91. (Pubitemid 29275073)
13. Tetley TD. Macrophages and the pathogenesis of COPD. Chest. 2002;121(5 Suppl):156S-9S. (Pubitemid 34497334)
14. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smokeinduced emphysema in mice. Science. 1997;277(5334):2002-4. (Pubitemid 27449144)
15. Owen CA. Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3(2):253-68. (Pubitemid 352037885)
16. Gendler SJ. MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia. 2001;6(3):339-53.
17. Hirasawa Y, Kohno N, Yokoyama A, Inoue Y, Abe M, Hiwada K. KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol. 1997;17(4):501-7. (Pubitemid 127500983)
18. Lu W, Hisatsune A, Koga T, Kato K, Kuwahara I, Lillehoj EP, et al. Cutting edge: enhanced pulmonary clearance of Pseudomonas aeruginosa by Muc1 knockout mice. J Immunol. 2006;176(7):3890-4. (Pubitemid 44264363)
19. Lillehoj EP, Hyun SW, Kim BT, Zhang XG, Lee DI, Rowland S, et al. Muc1 mucins on the cell surface are adhesion sites for Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol. 2001;280(1):L181-7.
20. Kato K, Lillehoj EP, Kai H, Kim KC. MUC1 expression by human airway epithelial cells mediates Pseudomonas aeruginosa adhesion. Front Biosci (Elite Ed). 2010;1(2):68-77.
21. Lillehoj EP, Kim H, Chun EY, Kim KC. Pseudomonas aeruginosa stimulates phosphorylation of the airway epithelial membrane glycoprotein Muc1 and activates MAP kinase. Am J Physiol Lung Cell Mol Physiol. 2004;287(4):L809-15. (Pubitemid 39249394)
22. Choi S, Park YS, Koga T, Treloar A, Kim KC. TNF-alpha is a key regulator of MUC1, an anti-inflammatory molecule, during airway Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol. 2011;44(2):255-60.
23. Spicer AP, Rowse GJ, Lidner TK, Gendler SJ. Delayed mammary tumor progression in Muc-1 null mice. J Biol Chem. 1995; 270(50):30093-101. (Pubitemid 26001684)
24. Ho MK, Springer TA. Tissue distribution, structural characterization, and biosynthesis of Mac-3, a macrophage surface glycoprotein exhibiting molecular weight heterogeneity. J Biol Chem. 1983;258(1):636-42. (Pubitemid 13165789)
25. Flotte TJ, Springer TA, Thorbecke GJ. Dendritic cell and macrophage staining by monoclonal antibodies in tissue sections and epidermal sheets. Am J Pathol. 1983;111(1):112-24. (Pubitemid 13117181)
26. Kato K, Lillehoj EP, Park YS, Umehara T, Hoffman NE, Madesh M, et al. Membrane-Tethered MUC1 Mucin Is Phosphorylated by Epidermal Growth Factor Receptor in Airway Epithelial Cells and Associates with TLR5 To Inhibit Recruitment of MyD88. J Immunol. 2012;16(188):2014-22.
27. Dunnill MS. Quantitative methods in the study of pulmonary pathology. Thorax. 1962;17:320-8.
28. Li Y, Dinwiddie DL, Harrod KS, Jiang Y, Kim KC. Antiinflammatory effect of MUC1 during respiratory syncytial virus infection of lung epithelial cells in vitro. Am J Physiol Lung Cell Mol Physiol. 2010;298(4):L558-63.
29. van Heeckeren AM, Tscheikuna J, Walenga RW, Konstan MW, Davis PB, Erokwu B, et al. Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice. Am J Respir Crit Care Med. 2000;161(1):271-9. (Pubitemid 30055936)
30. Lagente V, Le Quement C, Boichot E. Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases. Expert Opin Ther Targets. 2009;13(3):287-95.
31. Kim KC, Lillehoj EP. MUC1 mucin: a peacemaker in the lung. Am J Respir Cell Mol Biol. 2008;39(6):644-7.
32. Cash HA, Woods DE, McCullough B, Johanson WG Jr, Bass JA. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am Rev Respir Dis. 1979;119(3):453-9. (Pubitemid 9131392)
33. Starke JR, Edwards MS, Langston C, Baker CJ. A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia. Pediatr Res. 1987;22(6):698-702. (Pubitemid 18034115)
34. Heeckeren A, Walenga R, Konstan MW, Bonfield T, Davis PB, Ferkol T. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest. 1997;100(11):2810-5. (Pubitemid 28007550)
35. Koga T, Kuwahara I, Lillehoj EP, Lu W, Miyata T, Isohama Y, et al. TNF-alpha induces MUC1 gene transcription in lung epithelial cells: its signaling pathway and biological implication. Am J Physiol Lung Cell Mol Physiol. 2007;293(3):L693-701. (Pubitemid 47358832)
36. Zhang Z, Louboutin JP, Weiner DJ, Goldberg JB, Wilson JM. Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Toll-like receptor. Infect Immun. 2005;73(11):7151-60. (Pubitemid 41587612)
37. Ueno K, Koga T, Kato K, Golenbock DT, Gendler SJ, Kai H, et al. MUC1 mucin is a negative regulator of toll-like receptor signaling. Am J Respir Cell Mol Biol. 2008;38(3):263-8. (Pubitemid 351567694)
38. Kato K, Lu W, Kai H, Kim KC. Phosphoinositide 3-kinase is activated by MUC1 but not responsible for MUC1-induced suppression of Toll-like receptor 5 signaling. Am J Physiol Lung Cell Mol Physiol. 2007;293(3):L686-92. (Pubitemid 47358831)
39. Kyo Y, Kato K, Park YS, Gajhate S, Umehara T, Lillehoj EP, et al. Anti-inflammatory role of MUC1 mucin during nontypeable Haemophilus influenzae infection. Am J Respir Cell Mol Biol. 2012;46(2):149-56.
40. Jarrard JA, Linnoila RI, Lee H, Steinberg SM, Witschi H, Szabo E. MUC1 is a novel marker for the type II pneumocyte lineage during lung carcinogenesis. Cancer Res. 1998;58(23):5582-9. (Pubitemid 28551149)
41. Nagai A, Inano H, Matsuba K, Thurlbeck WM. Scanning electronmicroscopic morphometry of emphysema in humans. Am J Respir Crit Care Med. 1994;150(5 Pt 1):1411-5. (Pubitemid 24356660)
42. Snider GL. Emphysema: the first two centuries-and beyond: A historical overview, with suggestions for future research: Part. Am Rev Respir Dis. 1992;146(5 Pt 1):1334-44.
43. Barnes PJ. Medicine. Neutrophils find smoke attractive. Science. 2010;330(6000):40-1.
44. Russell REK, Thorley A, Culpitt SV, Dodd S, Donnelly LE, Demattos C, et al. Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol-Lung Cell Mol Physiol. 2002;283(4):L867-73.
45. Shapiro SD, Goldstein NM, Houghton AM, Kobayashi DK, Kelley D, Belaaouaj A. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am J Pathol. 2003; 163(6):2329-35. (Pubitemid 37466476)
46. Leco KJ, Waterhouse P, Sanchez OH, Gowing KL, Poole AR, Wakeham A, et al. Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest. 2001;108(6):817-29. (Pubitemid 32884192)
47. da Hora K, Valenca SS, Porto LC. Immunohistochemical study of tumor necrosis factor-alpha, matrix metalloproteinase-12, and tissue inhibitor of metalloproteinase-2 on alveolar macrophages of BALB/c mice exposed to short-term cigarette smoke. Exp Lung Res. 2005;31(8):759-70. (Pubitemid 41831704)
48. Pons AR, Sauleda J, Noguera A, Pons J, Barcelo B, Fuster A, et al. Decreased macrophage release of TGF-beta and TIMP-1 in chronic obstructive pulmonary disease. Eur Respir J. 2005;26(1): 60-6. (Pubitemid 40945932)
49. Taraseviciene-Stewart L, Douglas IS, Nana-Sinkam PS, Lee JD, Tuder RM, Nicolls MR, et al. Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease? Proc Am Thorac Soc. 2006;3(8):687-90. (Pubitemid 44788225)
50. Aoshiba K, Yokohori N, Nagai A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol. 2003;28(5):555-62. (Pubitemid 36543402)
51. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest. 2000;106(11): 1311-9.
52. Mahoney JA, Rosen A. Apoptosis and autoimmunity. Curr Opin Immunol. 2005;17(6):583-8. (Pubitemid 41506901)
53. Agata N, Ahmad R, Kawano T, Raina D, Kharbanda S, Kufe D. MUC1 oncoprotein blocks death receptor-mediated apoptosis by inhibiting recruitment of caspase-8. Cancer Res. 2008;68(15): 6136-44.
54. Kuwahara I, Lillehoj EP, Koga T, Isohama Y, Miyata T, Kim KC. The signaling pathway involved in neutrophil elastase stimulated MUC1 transcription. Am J Respir Cell Mol Biol. 2007;37(6): 691-8. (Pubitemid 350211639)
55. Guo X, Verkler TL, Chen Y, Richter PA, Polzin GM, Moore MM, et al. Mutagenicity of 11 cigarette smoke condensates in two versions of the mouse lymphoma assay. Mutagenesis. 2011;26(2):273-81.
56. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, Jones D, et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature. 2010;463(7278):184-90.